ContextVision Presents Q4 and Full Year 2012

Regulatory News:

ContextVision AB: (OSE:COV)

Q4 2012 HIGHLIGHTS

· Significant sales development

· Europe strengthened position

· 3D Ultrasound focus at RSNA in Chicago

· Product upgrades for Ultrasound, XR, MRI and iRV

Q4 2012 FINANCIAL DATA

· Sales of 20.5 MSEK (17.2)

· Operating result of 1.6 MSEK (1.4) and operating margin of 7.8% (7.9%).

· Earnings per share of 0,20 (0,12) SEK

This information was brought to you by Cision http://news.cision.com